Delirium associated with mianserin in demented patients

Journal of Clinical Psychopharmacology

Volumn 30, Issue 4, 2010, Pages 467-468

  Berilgen, M Said ^a  

^a Department of Neurology Faculty of Medicine FNrat (Euphrates) University Elazig   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CLOZAPINE; DONEPEZIL; MEMANTINE; MIANSERIN; PIRACETAM; QUETIAPINE; QUINAPRIL; RIVASTIGMINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT;

AGED; ALZHEIMER DISEASE; CASE REPORT; DELIRIUM; DELUSION; DRUG WITHDRAWAL; HALLUCINATION; HUMAN; INSOMNIA; LETTER; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; CHEMICALLY INDUCED; COMPLICATION; DEMENTIA; VERY ELDERLY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DELIRIUM; DEMENTIA; HUMANS; MALE; MIANSERIN;

EID: 77955149867     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181e634b6     Document Type: Letter

References (13)

1. Stahl SM. Essential Psychopharmacology: Neuroscientific Basis and Practical Application. 2nd ed. Cambridge: Cambridge University Press; 2000.
2. Burrows GD, Kremer CM. Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol. 1997;17:34S-39S.
3. Fick DM, Agostini JV, Inouye SK. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2002;50: 1723-1732.
4. O'Keeffe S, Lavan J. The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc. 1997;45: 174-178.
5. Baker FM, Wiley C, Kokmen E, et al. Delirium episodes during the course of clinically diagnosed Alzheimer's disease. J Natl Med Assoc. 1999;91:625-630.
6. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669-676.
7. van der Mast RC. Pathophysiology of delirium. J Geriatr Psychiatry Neurol. 1998;11:138-145.
8. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15:15-28.
9. Olivier B, van Wijngaarden I, Soudijn W. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review. Eur Neuropsychopharmacol. 2000;10:77-95.
10. Uchiyama M, Tanaka K, Isse K, et al. Efficacy of mianserin on symptoms of delirium in the aged: an open trial study. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20:651-656.
11. Bonne O, Shalev AY, Bloch M. Delirium associated with mianserin. Eur Neuropsychopharmacol. 1995;5:147-149.
12. Fisch RZ, Alexandrowitz A. Delirium in a patient treated with mianserin. Br Med J (Clin Res Ed). 1988;296:137.
13. Szabo TS, Gould TD, Manji HK. Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ed. Arlington, VA: American Psychiatric Publishing Inc; 2004:3-52.